Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 83 kDa (CEP83) is a centriolar protein that localizes to the distal appendages of mother centrioles, where it is essential for anchoring the centriole to the cell membrane and initiating the formation of primary cilia[1][2]. CEP83 recruits other distal appendage proteins during ciliogenesis and thus controls the assembly and function of primary cilia, which play critical roles in cellular signaling and development. Mutations in CEP83 cause defective ciliogenesis and disrupted mesodermal patterning, especially impairing the formation of intermediate mesoderm and kidney progenitor cells, and are associated clinically with infantile nephronophthisis—a severe pediatric kidney disease—and potentially other organ defects deriving from aberrant mesodermal differentiation[1][2]. While fundamental for development and disease modeling, there are currently no drugs known to directly target CEP83, and its main clinical relevance derives from its role as a genetic disease gene and a developmental biology marker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 83 kDa (CEP83).